Real World Treatment Patterns in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Switching from First Line Ibrutinib to Acalabrutinib

被引：4
|
作者：
Jacobs, Ryan [1 ]
Wang, Ruibin [2 ]
He, Jinghua [2 ]
Lu, Xiaoxiao [3 ]
Wu, Linda [3 ]
Khan, Wasiulla [3 ]
Qureshi, Zaina P. [3 ]
Levy, Moshe Yair [4 ]
机构：
[1] Atrium Hlth, Hematol, Levine Canc Inst, Charlotte, NC USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Janssen Sci Affairs LLC, Horsham, PA USA
[4] Texas Oncol Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-168081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8017 / 8018
页数：2
相关论文
共 50 条
  • [1] Real-World Adherence to First-Line Ibrutinib and Acalabrutinib Single-Agent Among Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina
    He, Jinghua
    Qian, Yi
    Huang, Qing
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Jacobs, Ryan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S280 - S281
  • [2] Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma
    Jacobs, Ryan W.
    Teschemaker, Anna
    Hakre, Shweta
    Tian, Hongping
    Pyrih, Nick
    Wahlstrom, Svea K.
    Cui, Lianzhou
    [J]. BLOOD, 2023, 142
  • [3] Early Adherence and Persistence to First-Line Ibrutinib or Acalabrutinib Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Atrial Fibrillation
    Fradley, Michael
    Lafeuille, Marie-Helene
    Emond, Bruno
    Crawford, Samuel
    Chen, Naijun
    Volodarsky, Raisa
    Nielsen, Jacqueline
    Srivastava, Bhavini Patel
    [J]. BLOOD, 2022, 140 : 10983 - 10984
  • [4] Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Roeker, Lindsey E.
    DerSarkissian, Maral
    Ryan, Kellie
    Chen, Yan
    Duh, Mei Sheng
    Wahlstrom, Svea K.
    Hakre, Shweta
    Yu, Louise
    Guo, Helen
    Mato, Anthony R.
    [J]. BLOOD ADVANCES, 2023, 7 (16) : 4291 - 4301
  • [5] Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinib
    Jacobs, Ryan
    Lu, Xiaoxiao
    Emond, Bruno
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Khan, Wasiulla
    Wu, Linda H.
    Qureshi, Zaina P.
    Levy, Moshe Yair
    [J]. FUTURE ONCOLOGY, 2024, 20 (01) : 39 - 53
  • [6] REAL-WORLD ECONOMIC OUTCOMES OF FIRST-LINE (1L) IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
    Challagulla, S.
    Lee, P.
    Kistler, K.
    Douyon, L.
    Lai, D.
    Iyengar, R.
    [J]. VALUE IN HEALTH, 2021, 24 : S38 - S38
  • [7] Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
    Lu, Xiaoxiao
    Emond, Bruno
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Khan, Wasiulla
    Wu, Linda H.
    Qureshi, Zaina P.
    Jacobs, Ryan
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2073 - 2084
  • [8] Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Philip Lee
    Kristin D. Kistler
    Luc Douyon
    Raisa Volodarsky
    Alex Young
    Sudeep Karve
    Swetha Challagulla
    [J]. Drugs - Real World Outcomes, 2023, 10 : 11 - 22
  • [9] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Awan, Farrukh T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 13 - 14
  • [10] Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Lee, Philip
    Kistler, Kristin D.
    Douyon, Luc
    Volodarsky, Raisa
    Young, Alex
    Karve, Sudeep
    Challagulla, Swetha
    [J]. DRUGS-REAL WORLD OUTCOMES, 2023, 10 (01) : 11 - 22
12345